Stay updated on ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial
Sign up to get notified when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.

Latest updates to the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page
- Check5 days agoChange DetectedA site interface revision marker was updated from version v3.5.2 to v3.5.3, reflecting a non-content update to the page’s release/build labeling.SummaryDifference0.1%

- Check13 days agoChange DetectedThe record history now includes a new revision entry (v3.5.2) and removes the older revision (v3.5.0).SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check41 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the history page.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry v3.4.3 (2026-03-11) was added to the Record History, and the previous revision v3.4.2 (2025-12-30) was listed in deletions.SummaryDifference0.5%

- Check77 days agoChange DetectedA new history entry Revision: v3.4.2 was added and Revision: v3.4.1 removed; there are no changes to study data or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded revision entry v3.4.1 to the record history and removed v3.4.0. This reflects an internal version update to the page rather than a change to the study data.SummaryDifference0.1%

Stay in the know with updates to ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.